Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.

The prophylactic and therapeutic efficacy of interleukin-12 was studied by using murine models of herpes simplex virus infection. Prophylactic administration consisted of two intraperitoneal doses of interleukin-12 given 48 and 24 h prior to infection. Therapeutic intraperitoneal administration of i...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Virol
Hauptverfasser:	Carr, J A, Rogerson, J, Mulqueen, M J, Roberts, N A, Booth, R F
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1997
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192132/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9311865/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.10.7799-7803.1997
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!